SCYNEXIS
SCYX
$2.42
Share price
2.77%
Change (1 day)
-7.82%
Change (1 year)
Categories
SCYNEXIS (SCYX) - P/B ratio
P/B ratio as of June 2024 : 1.20
According to SCYNEXIS's latest financial reports the company has a price-to-book ratio of 1.20.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
SCYNEXIS - P/B ratio (from 2014 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 1.14 | -92.78% |
| 2022-12-31 | 15.8 | 345.01% |
| 2021-12-31 | 3.54 | -45.36% |
| 2020-12-31 | 6.48 | -5.72% |
| 2019-12-31 | 6.87 | 828.92% |
| 2018-12-31 | 0.7401 | -76.09% |
| 2017-12-31 | 3.09 | 40.8% |
| 2016-12-31 | 2.20 | 6.77% |
| 2015-12-31 | 2.06 | -18.99% |
| 2014-12-31 | 2.54 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | 0.1577 | -86.84% | 🇮🇱 Israel |
 Catalyst Pharmaceuticals CPRX | 3.39 | 182.90% | 🇺🇸 USA |
 Catalent CTLT | 2.69 | 124.27% | 🇺🇸 USA |
 KemPharm KMPH | 2.34 | 95.01% | 🇺🇸 USA |